OptimizeRx Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $109.4 | $92.1 | $71.5 | $62.5 | $61.3 |
| Operating income | $11.7 | -$13.7 | -$26.4 | -$12.3 | $0.4 |
| Net income | $5.1 | -$20.1 | -$17.6 | -$11.4 | $0.4 |
| Cash Flow Statement | |||||
| Free cash flow | $18.7 | $4.8 | -$7.3 | $10.6 | $0.6 |
| Share repurchases | — | — | $7.5 | $20.0 | — |
Shares outstanding 18.8M · Free float 67.2%
Annual filing data through FY ended December 31, 2025; float as of September 10, 2026.